Home » Archives by category » Psychology news (Page 1070)

Insulin-like growth factor linked to hippocampal hyperactivity in Alzheimer’s disease

The insulin-like growth factor 1 receptor (IGF-1R), the ‘master’ lifespan regulator, plays a vital role in directly regulating hippocampal hyperactivity in the brain, report scientists. The researchers hope their findings can be used to indicate a new …

Team-based treatment for first episode psychosis found to be high value

NIH-funded study shows early intervention is more cost-effective than typical care.

New MRI technique offers faster diagnosis of multiple sclerosis

A new way of using MRI scanners to look for evidence of multiple sclerosis in the brain has been successfully tested by researchers. Multiple sclerosis (MS) is notoriously difficult to diagnose as it has many symptoms but not all sufferers experience a…

Abnormal gene is a triple threat in driving pediatric brain tumors

An abnormal fused gene that drives pediatric brain tumors poses a triple threat, operating simultaneously through three distinct biological mechanisms — the first such example in cancer biology. This finding potentially offers triple benefits as well …

No link found between subcortical brain volumes, genetic risk for schizophrenia

A new study evaluated the relationship between common genetic variants implicated in schizophrenia and those associated with subcortical brain volumes, and found no evidence of genetic overlap between schizophrenia risk and subcortical volume measures.

New research replicates a folding human brain in 3D

Understanding how the brain folds could help unlock the inner workings of the brain but the process has long remained a mystery. Now, by replicating a folding human brain in 3D, researchers have shown that while many molecular processes are important i…

Follow-up care low among adolescents with new depression symptoms

While most adolescents with newly identified depression symptoms received some treatment within three months, some of them did not receive any follow-up care and 40 percent of adolescents…

Allergan’s Rapastinel receives FDA breakthrough therapy designation for adjunctive treatment of Major Depressive Disorder

Allergan plc., a leading global pharmaceutical company has announced that its Phase III ready investigational medication rapastinel (GLYX-13) received Breakthrough Therapy designation from the U.S.

Future help for stroke patients with language problems

A new method of analysis to distinguish between stroke patients with language problem has been developed by a brain researcher. The result may be individualized treatment for each patient.

Good cosmetic outcomes, improved quality of life with full facial feminization surgery

For patients with gender dysphoria undergoing male-to-female transformation, a stepwise approach to facial feminization surgery (FFS) leads to good cosmetic outcomes along with psychological…